Tissue Engineering is fastest growing segment fueling the growth of Biosurgery Market
 |
| Biosurgery Market |
The global Biosurgery Market is
estimated to be valued at US$ 15870.09 Mn in 2023 and is expected to exhibit a
CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market Overview:
Biosurgery products are used to
prevent bleeding and help healing of tissues during or after surgical
procedures. These include adhesion barriers, hemostatic agents, soft tissue repairs,
and bone graft substitutes which help minimize blood loss and assist repair of
damaged tissues.
Market key trends:
One of the key trends in the
biosurgery market is the rising adoption of tissue engineering products. Tissue
engineering utilizes cells, engineering, and materials methods to grow tissues
and repair or replace damaged tissues. It has emerged as a promising approach
for developing alternatives to traditional organ transplantation. Advances in
areas of stem cell therapy, 3D tissue printing, and development of acellular
scaffolds are fueling the demand for tissue engineering products in biosurgery
procedures.
Segment Analysis
The global biosurgery market can
be segmented into hemostatic agents, tissue sealants, and adhesion barriers. Among
these, the hemostatic agents segment dominates the market and accounts for over
50% market share. This is because hemostatic agents are widely used for
controlling blood loss during surgeries. Different types of hemostatic agents
like active, passive, and combination hemostatic agents are used depending on
the extent of bleeding and surgery type.
Key Takeaways
The Global
Biosurgery Market Size is expected to witness high growth, exhibiting a
CAGR of 6.9% over the forecast period, due to increasing number of surgical
procedures worldwide, rising prevalence of chronic diseases, and growing
geriatric population.
Regional analysis
North America dominates the global
biosurgery market and is expected to continue its dominance over the forecast
period. This is attributed to the presence of major key players, high
healthcare spending, and advanced hospital infrastructure in the region. Asia
Pacific is expected to exhibit the fastest growth rate owing to increasing
healthcare expenditure, growth in medical tourism, and improving healthcare
facilities in emerging countries like China and India.
Key players
Key players operating in the
biosurgery market are Betatech Medical, Hemostasis LLC, CryoLife Inc., CSL
Limited, Medtronic PLC, Johnson & Johnson, B.Braun Melsungen AG, Baxter
International Inc., Integra Lifesciences Holdings Corporation, and Becton,
Dickinson and Company (CR Bard), among others. Betatech Medical and Hemostasis
LLC specialize in developing hemostatic agents for effective blood loss
management. CryoLife Inc. focuses on advanced biomaterials and medical devices
for cardiovascular and vascular applications.
Read more
https://www.dailyprbulletin.com/biosurgery-market-size-share-growth-outlook-2023/
Comments
Post a Comment